TY - JOUR
T1 - Neuropsychological features of progranulin-associated frontotemporal dementia
T2 - a nested case-control study
AU - Lima, Marisa
AU - Tábuas-Pereira, Miguel
AU - Duro, Diana
AU - Durães, João
AU - Vieira, Daniela
AU - Baldeiras, Inês
AU - Almeida, Maria
AU - Santana, Isabel
N1 - Funding Information:
Heuer HW, Wang P, Rascovsky K, Wolf A, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber DE, Caso C, Coppola G, Dickerson B, Dickinson S, Domoto-Reilly K, Faber K, Ferrall J, Fields J, Fishman A, Fong J, Foroud T, et al. (2020) Comparison of?sporadic?and?familial?behavioral?variant?frontotemporal?dementia?(FTD)?in?a? North American cohort. Alzheimers Dement 16:60-70. Hogan?DB,?Jetté?N,?Fiest?KM,?Roberts?JI,?PearsonD,SmithEE,R oachP,Kirk? A, Pringsheim T, Maxwell CJ (2016) The Prevalence and Incidence of Author contributions ? Concept and design P MTP唀 ML 唀 IS 嘀 data acquisition P Frontotemporal?Dementia:?a?Systematic?Review.?Can?J?Neurol?Sci?43?Suppl?1:S96- all authors 嘀 data analysis and statistical analysis P MTP唀 ML 唀 IS 唀 I? 嘀 Hosokawa M, Tetsuaki A (2019) Progranulin and Frontotemporal Lobar 109. manuscript preparation 唀 editing and review P MTP唀 IS 唀 ML 唀 ??堀 All authors approved the final version of this paper ? Degeneration.?In:?Progranulin?and?central?nervous?system?disorders?(Hara?H,? Conflicts of interest 圀 The authors declares no conflict of interest ? Hosokawa M, Nakamura S, Shimohata T, Nishihara M, eds), pp35-69. Singapore: Financial support: ML was supported by Portuguese Foundation for HughesCP,Ber g?L,?Danziger? ,CobenLA ,?Martin?RL?(1982)?A?new?clinical?scale?for?Springer. Science and Technology 縀FCT 缃唀 No 堀 SFRH 氀ᄀ᠃氃氃? Institutional review board statement 圀 This study was reviewed and the?staging?of?dementia.?Br?J?Psychiatry?140:566-572.? approved by the Institutional Ethics Committee of Centro Hospitalar e CRJr,ShiungM,Knopman?DS,?Josephs?KA,?Parashos?SA,Rademakers?R,?Hutton?Kelley?BJ,Haidar?,Boe veBF,BakerM,Gr aff-Radford?NR,?KrefftT,Frank?AR,?Jack? Universitário de Coimbra 唀 Portugal 縀CE 爃氃缀 on June 唀 ? Declaration of patient consent 圀 The authors certify that they have M, Pickering-Brown S, Adamson J, Kuntz KM, Dickson DW, Parisi JE, Smith GE, obtained all appropriate patient consent forms 堀 In the forms the patients et?al.?(2009)?Prominent?phenotypic?variability?associated?with?mutations?in? have given their consent for their images and other clinical information to Progranulin. Neurobiol Aging 30:739-751. be reported in the journal 堀 The patients understand that their names and Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, Hahn- initials will not be published and due efforts will be made to conceal their Barma V, van der Zee J, Clot F, Bakchine S, Puel M, Ghanim M, Lacomblez L, identity 唀 but anonymity cannot be guaranteed ? MikolJ ,?DeramecourtV ,LejeuneP ,delaSa yetteV ,Belliar dS,V ercelletto?M,? Reporting statement ? This study followed the STrengthening the Meyrignac?C,?et?al.?(2008)?Phenotype?variability?in?progranulin?mutation?carriers:? Reporting of O?servational studies in Epidemiology 縀STRO?E 缀 statement ?a?clinical,?neuropsychological,?imaging?and?genetic?study.Br ain?131(Pt?3):732- Biostatistics statement 圀 The statistical methods of this study were 746. reviewed by the biostatistician of Coimbra ? s University and Hospital Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J, Cannon A, Adamson Center in Portugal ? J,?Feldman?H,?Lindholm?C,?Melquist?S,?Pettman?R,?SadovnickAD,Dw osh?E,? Copyright license agreement: The Copyright License Agreement has been ?hiteheart?S? ,Hutt onM,Pick ering-Brown?SM?(2006)?A?family?with?tau- signed by all authors before publication ? negative?frontotemporal?dementia?and?neuronal?intranuclearinclusionslink ed? Data sharing statement: ?ata is only available by request to the to chromosome 17. Brain 129:853-867. corresponding author and depending on the idea behind the project and McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk the aims and methods of the requirement 堀 WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Plagiarism check: Checked twice by iThenticate 堀 Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis Peer review: Externally peer reviewed 堀 of?dementia?due?to?Alzheimer’sdisease:r ecommendations?from?the?National? Open access statement: This is an open access journal 唀 and articles Institute?on?Aging-Alzheimer’sAssocia tion?workgroups?on?diagnostic?guidelines? are distributed under the terms of the Creative Commons Attribution ? Moreno F, Indakoetxea B, Barandiaran, M, Alzualde A, Gabilondo A, Estanga A, for Alzheimer’s disease. Alzheimers Dement 7:263-269. NonCommercial 爀ShareAlike 堃 License 唀 which allows others to remix 唀 Ruiz?J,?Ruibal?M,?Bergareche?A,Martí-MassóJF ,deMunainAL(2009)? tweak 唀 and build upon the work non 爁?ommercially 唀 as long as appropriate credit is given and the new creations are licensed under the identical “Frontotemporoparietal”?dementia:?clinical?phenotype?associated?with?the?c.? terms ? 709-1GAN?A?PGRN?mutation.?Neurology?73:1367-1374.?? Additional files 圀 Poos JM, Jiskoot LC, Papma, JM, van Swieten JC, van den Berg E (2018) Meta- Additional file 圀 Ethical Approval ?ocumentation 縀Portuguese 缃? analytic?review?of?memory?impairment?in?behavioral?variant?frontotemporal? Additional file 圀 Model consent form 縀Portuguese 缃? Ramanan S, Bertoux M, Flanagan E, Irish M, Piguet O, Hodges JR, Hornberger dementia.?J?Int?Neuropsychol?Soc?24:593-605.??
Funding Information:
Funding: ML was supported by Portuguese Foundation for Science and Technology 縀FCT 缃唀 No 堀 SFRH 氀ᄀ᠃氃氃? How to cite this article: Lima M 唀 Tábuas 爀Pereira M 唀 ?uro ?唀 ?urães J唀 Vieira ?唀 ?aldeiras I 唀 Almeida MR 唀 Santana I 縃缀 Neuropsychological features of progranulin 爁ȁ送送紁ခ崁ȁ?ed frontotemporal dementia P a nested case 爁?ontrol study 堀 Neural Regen Res 縃缃P 爃堀
Publisher Copyright:
© 2021 Wolters Kluwer Medknow Publications. All rights reserved.
PY - 2021/5
Y1 - 2021/5
N2 - The distinction between sporadic and genetic behavioural-variant frontotemporal dementia (bvFTD) regarding some neuropsychological (NP) features remains challenging. Specifically, progranulin (GRN)-associated bvFTD frequently presents with early episodic memory impairment and some degree of parietal dysfunction which are supporters of Alzheimer's disease (AD) diagnosis. In this context, we aimed to characterize the NP profile of GRN-bvFTD as compared to sporadic-bvFTD and AD in patients with mild dementia (Mini-Mental State Examination score ≥ 17 and Clinical Dementia Rating Scale score ≤ 1. We identified 21 patients at Centro Hospitalar e Universitário de Coimbra, Portugal with GRN mutations belonging to fifteen different families. As our focus was bvFTD variants, FTD-related aphasic forms (3 patients) were excluded. The remaining 18 GRN-bvFTD were further matched with 18 sporadic-bvFTD and 18 AD patients according to disease staging, age and education. All patients completed the Mini-Mental State Examination, Montreal Cognitive Assessment (MoCA) and a comprehensive NP assessment battery. Results were converted into z-scores. Differences between groups in individual NP measures and NP domains were assessed through non-parametric tests (Kruskal-Wallis test analysis) and eta squared (ŋ2) was calculated as a measure of effect size. Group comparisons show that GRN patients have worse performances on verbal retrieval processes (P = 0.039, ŋ2= 0.110) and visuoconstructive abilities (P = 0.039, ŋ2= 0.190) than sporadic bvFTD forms. When compared to AD, GRN patients present a higher impairment in frontal (P = 0.001, ŋ2= 0.211) and parietal (P = 0.041, ŋ2= 0.129) measures and a better performance in memory tasks (P = 0.020, ŋ2= 0.120). Sporadic-bvFTD forms are worse than AD in frontal measures (P = 0.032, ŋ2= 0.200), being better in both memory (P = 0.010, ŋ2= 0.131) and visuospatial skills (P = 0.023, ŋ2= 0.231). Considering these results, we conclude that GRN-bvFTD patients present a NP profile that associates the typical patterns of FTD and AD deficits. This is particularly expressive in visuoconstructive abilities, which was the more discriminative feature between groups, followed by episodic verbal memory. This study was approved by the Institutional Ethics Committee of Centro Hospitalar e Universitário de Coimbra, Portugal (CE-029/2019) on June 24, 2019.
AB - The distinction between sporadic and genetic behavioural-variant frontotemporal dementia (bvFTD) regarding some neuropsychological (NP) features remains challenging. Specifically, progranulin (GRN)-associated bvFTD frequently presents with early episodic memory impairment and some degree of parietal dysfunction which are supporters of Alzheimer's disease (AD) diagnosis. In this context, we aimed to characterize the NP profile of GRN-bvFTD as compared to sporadic-bvFTD and AD in patients with mild dementia (Mini-Mental State Examination score ≥ 17 and Clinical Dementia Rating Scale score ≤ 1. We identified 21 patients at Centro Hospitalar e Universitário de Coimbra, Portugal with GRN mutations belonging to fifteen different families. As our focus was bvFTD variants, FTD-related aphasic forms (3 patients) were excluded. The remaining 18 GRN-bvFTD were further matched with 18 sporadic-bvFTD and 18 AD patients according to disease staging, age and education. All patients completed the Mini-Mental State Examination, Montreal Cognitive Assessment (MoCA) and a comprehensive NP assessment battery. Results were converted into z-scores. Differences between groups in individual NP measures and NP domains were assessed through non-parametric tests (Kruskal-Wallis test analysis) and eta squared (ŋ2) was calculated as a measure of effect size. Group comparisons show that GRN patients have worse performances on verbal retrieval processes (P = 0.039, ŋ2= 0.110) and visuoconstructive abilities (P = 0.039, ŋ2= 0.190) than sporadic bvFTD forms. When compared to AD, GRN patients present a higher impairment in frontal (P = 0.001, ŋ2= 0.211) and parietal (P = 0.041, ŋ2= 0.129) measures and a better performance in memory tasks (P = 0.020, ŋ2= 0.120). Sporadic-bvFTD forms are worse than AD in frontal measures (P = 0.032, ŋ2= 0.200), being better in both memory (P = 0.010, ŋ2= 0.131) and visuospatial skills (P = 0.023, ŋ2= 0.231). Considering these results, we conclude that GRN-bvFTD patients present a NP profile that associates the typical patterns of FTD and AD deficits. This is particularly expressive in visuoconstructive abilities, which was the more discriminative feature between groups, followed by episodic verbal memory. This study was approved by the Institutional Ethics Committee of Centro Hospitalar e Universitário de Coimbra, Portugal (CE-029/2019) on June 24, 2019.
KW - Alzheimer's disease
KW - Behavioral variant frontotemporal dementia
KW - Cognitive profile
KW - Frontotemporal dementia
KW - Genetics
KW - Memory
KW - Neuropsychology
KW - Progranulin
KW - Visuoconstructive ability
UR - http://www.scopus.com/inward/record.url?scp=85097076140&partnerID=8YFLogxK
U2 - 10.4103/1673-5374.297082
DO - 10.4103/1673-5374.297082
M3 - Article
C2 - 33229728
AN - SCOPUS:85097076140
SN - 1673-5374
VL - 16
SP - 910
EP - 915
JO - Neural Regeneration Research
JF - Neural Regeneration Research
IS - 5
ER -